Dicerna Pharmaceuticals Inc

NASDAQ:DRNA  
38.26
+0.14 (+0.37%)
Earnings Announcements

Dicerna Announces Third Quarter 2021 Financial Results And Provides A Business Update

Published: 11/09/2021 12:47 GMT
Dicerna Pharmaceuticals Inc (DRNA) - Dicerna Announces Third Quarter 2021 Financial Results and Provides a Business Update.
Q3 Loss per Share $0.22.
Q3 Revenue $63 Million.
Cash Runway Extends Into 2025.
Revenue is expected to be $41.26 Million
Adjusted EPS is expected to be -$0.47

Next Quarter Revenue Guidance is expected to be $34.02 Million
Next Quarter EPS Guidance is expected to be -$0.67

More details on our Analysts Page.